New clinical trial at UTHealth Houston tests gene therapy vector that delivers drug aimed at stopping overactive bladder in patients with spinal cord injury | Newswise
A modified herpes virus that targets spinal cord nerve cells to treat neurogenic bladder in people with spinal cord injury is underway in a first-in-human clinical trial by UTHealth Houston at TIRR Memorial Hermann. Neurogenic bladder, also called neurogenic lower urinary tract dysfunction, often occurs after a spinal cord injury. The spinal cord helps coordinate bladder storage and voiding….